P eripartum cardiomyopathy (PPCM) is an idiopathic myocardial disease presenting toward the end of pregnancy or in the months following delivery with heart failure secondary to left ventricular (LV) systolic dysfunction (1). Left ventricular ejection fraction (LVEF) at diagnosis is usually markedly reduced, averaging in the published data at around 30% (2-5). Early recovery (within 2 to 6 months) with partial or complete restoration of cardiac function is an additional characteristic of PPCM and has been described in the majority of patients diagnosed with this condition in the United States and Europe (5-7). At the same time, however, PPCM is a leading cause of pregnancy-related nonobstetric morbidity and mortality. Markedly reduced cardiac function and failure to recover reported in 10% to 30% can be associated with major adverse events, including life threatening arrhythmias, thromboembolic complications, clinical deterioration with a need for aggressive therapy (including cardiac mechanical support and heart transplantation), and death (2,5,6). For these reasons, the ability to identify early predicators of failure to recover in women diagnosed with PPCM is of obvious importance and can help to prevent complications and improve outcome.
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In this issue of JACC: Heart Failure, Damp et al. (8) report that higher relaxin-2 levels (>6.4 pg/ml) soon (0 to 11 days) after delivery were associated with myocardial recovery at 2 months. The authors postulated that higher levels of relaxin-2 may result in less LV remodeling secondary to its vasodilatory effect, as well as its effect to decrease inflammation, increase angiogenesis, and decrease fibrosis. 
BASELINE LVEF
In a retrospective evaluation of 182 women with PPCM included in the University of Southern California database, recovery of LV function (LVEF $50%) at 6 months after diagnosis was demonstrated in 61% of the patients (9) . Multivariate analysis identified baseline LVEF >30% as a significant predictor of recovery. Recovery was 6.4-fold higher in women with LVEF >30% (group III) and 3.9-fold higher in women with LVEF 20% to 29% (group II) compared with women with LVEF 10% to 19% (group I). A total of 63% of group I patients failed to achieve full recovery compared with 32% of group II and 21% of group III. In addition, failure to achieve LVEF $30% was noted in 30% of group I and 13% of group II patients.
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